Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Glutamine and Reduced Oral Mucositis Severity

Research synthesisModerate evidenceSmall effect5 studies · 3 beneficial · 2 neutral · 0 harmful

Across 5 studies, 3 reported beneficial effects of L-glutamine on reducing oral mucositis severity, with effect sizes ranging from small to moderate. The evidence includes a meta-analysis and a recent RCT showing statistically significant benefits, while 2 studies (both systematic reviews or RCTs) found neutral effects. The median study duration was 49 days (reported in 1 study), and the most studied population is cancer patients undergoing treatment.

  • Studied populations: cancer patients (including head and neck cancer and pediatric cancer) receiving chemotherapy or radiotherapy

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. Two of the five studies did not find significant effects, and doses were inconsistently reported across studies.

Generated Jul 12, 2026
Doses used in studies
  • g/day: 5 (median 5, IQR 55) 1 study
Time to effect
Median: 7 weeks · IQR 7 weeks7 weeks · Range 7 weeks7 weeks — Reported in 1 of 5 studies
Safety in these studies
5 of 5 papers
Back to top